+ Watch ALXN
on My Watchlist
A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.
everyone loves this stock. It wasn't just added to the S&P 500 for no reason. Earnings, Sales, ROE are all exceptional. Created a niche market for rare diseases and management will continue to outperform expectations.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions